Patterson Companies, Inc. (PDCO) analyst actions
Rating and price-target actions on PDCO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PDCO overview →
No PDCO analyst action events in the measured window.
Nothing matched in the current window — the PDCO overview has every event we measure for this name.
Get an email when PDCO moves on news →Keep exploring
More PDCO: earnings → · SEC filings → · PDCO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GlycoMimetics, Inc. (GLYC) | 144 | +0.53% | 54% |
| Mustang Bio, Inc. (MBIO) | 144 | -0.46% | 41% |
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
| Cara Therapeutics, Inc. (CARA) | 143 | -0.56% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.